TheBody.com/TheBodyPRO.com covers The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012)

ICAAC 2012 Newsroom

Conference Coverage at TheBodyPRO.com | ICAAC 2012 Web Highlights

Conference Coverage at TheBodyPRO.com

Drug News From ICAAC (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Reyataz and Kidney Stones (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Zinc Finger Gene Therapy Continues to Show Promise (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Once-Daily Pills Improve Outcomes (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Long-Acting Drug in Development (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Black People Experience Less Viral Suppression (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Aware of the Heart (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Delay Antiretroviral Therapy in HIV Patients With Cryptococcal Meningitis, Researchers Recommend (November 5, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Building a Better Tenofovir: Oral Prodrug GS-7340 Outperforms "Old" Tenofovir, Research Finds (October 26, 2012)
In The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) , from TheBodyPRO.com
Even HIV-Infected Men With Undetectable HIV in Blood May Shed HIV in Semen (October 11, 2012)
In The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012), from TheBodyPRO.com

VIEW ALL ARTICLES

Home

All Headlines

Previous Conferences

Drug News From ICAAC
Reyataz and Kidney Stones
Zinc Finger Gene Therapy Continues to Show Promise
Once-Daily Pills Improve Outcomes
Long-Acting Drug in Development
More >>

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.